Conversely, the degradation rate of the TTRD18G-GFP substrate was assessed in high PrP-expressing CR7 glioblastoma cells that underwent CRISPR/Cas9-mediated PrP knockout (KO) (Fig. 5c). Here, PRNP is linked to glioblastoma.